Has Bill Huang, MD received payments from drug or device companies?

Yes. Drug and device makers reported $89,364 in general payments to Bill Huang, MD across 212 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bill Huang, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bill Huang, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bill Huang, MD

Orthopaedic Surgery · Everett, WANPI 1356361588

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (37.3%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 73.8% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $38,309 and has fallen 79.2% since, to $7,982 in 2025. Among orthopaedic surgery clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$89,364in general payments, 2019–2025

Across 212 payments — averaging $421.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$66K
Orthalign Inc$11K
Think Surgical, Inc.$9K
Pacira Pharmaceuticals Incorporated$2K
Intuitive Surgical$239
Johnson & Johnson$200
plus $544 from 8 others

$396,120in research payments, 2019–2025

Across 83 payments — averaging $4772.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Smith+Nephew$396K

What the payments were for

Consulting fees$33,35537%
Speaking & faculty fees$22,76025%
Travel & lodging$25,03328%
Food & beverage$8,2169%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	157	$65,947
Orthalign Inc	22	$11,492
Think Surgical, Inc.	6	$9,040
Pacira Pharmaceuticals Incorporated	4	$1,902
Intuitive Surgical	2	$239
Johnson & Johnson(2 entities)	3	$200
Stryker	2	$197
Avanos Medical	4	$147
KCI USA, Inc.	1	$74
Fidia Pharma USA Inc.	6	$35
Orthofix Medical, Inc.	2	$35
Ultragenyx Pharmaceutical Inc.	1	$21
Molnlycke Health Care US, LLC	1	$20
Zimmer Biomet	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$89,364 in reported general payments places this provider in the 90th percentile of 495 orthopaedic surgery providers in Washington.

See all orthopaedic surgery providers in Washington →

Medicare billing

Part B allowed, 2024

$195,958

Medicare patients

262

Services billed

2,104

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	232	$2,622
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	39	$484
Celecoxib	20	$260
Hydromorphone Hcl	42	$221
Amoxicillin	178	$175
Oxycodone Hcl	19	$165
Hydroxyzine Pamoate	32	$122
Tramadol Hcl	16	$86
Clindamycin Hcl	42	$66
Cyclobenzaprine Hcl	11	$53

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Everett

William BarrettRenton$7.7M
James PritchettSeattle$6.4M
James CrutcherSeattle$3.5M
Keith MayoSeattle$3.1M
Matthew SaltzmanSeattle$1.8M
Tim LovellSpokane$1.8M
Timothy AltonRenton$1.5M
Burt YaszaySeattle$1.3M
Sean ToomeySeattle$1.2M
Richard WilliamsonMount Vernon$1.1M

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →